+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 14: environmental quality and control (continued)



Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 14: environmental quality and control (continued)



International Journal of Pharmaceutical Compounding 13(4): 322-329



The design and location of the primary engineering controls within a compounding facility in order to maitain an expected controlled environment is well worth the time and expense involved. If the airflow within the compounding area is not properly designed and maintained, the results can be tragic to not only the compounding personnel but to those patients for whom the preparations are being compounded. Knowledge of the placement of primary engineering controls, air sampling, cleaning and disinfecting, and additional personnel requirements in the area of sterile compounding are essential. Once the guidelines have been studied, compounding personnel should apply practicality and common sense to avoid problems with compounded sterile preparations.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 051761088

Download citation: RISBibTeXText

PMID: 23966523


Related references

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 18: verification of automated compounding devices for parenteral nutrition compounding and finished preparation release checks and tests. International Journal of Pharmaceutical Compounding 14(2): 142-149, 2010

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 12. International Journal of Pharmaceutical Compounding 13(2): 146-150, 2009

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 11. International Journal of Pharmaceutical Compounding 13(1): 56-62, 2009

Basics of compounding; considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 13. International Journal of Pharmaceutical Compounding 13(3): 234-238, 2009

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding sterile preparations, part 6: 2008 revisions to chapter 797. International Journal of Pharmaceutical Compounding 12(2): 136-144, 2008

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 8: stability and beyond-use dating. International Journal of Pharmaceutical Compounding 12(4): 344-353, 2008

Basics of compounding: the responsibilities of compounding personnel in implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 2. International Journal of Pharmaceutical Compounding 11(4): 313-323, 2007

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 4: considerations in selection and use of disinfectants and antiseptics. International Journal of Pharmaceutical Compounding 11(6): 492-499, 2007

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 16: suggested standard operating procedures. International Journal of Pharmaceutical Compounding 13(6): 546-553, 2009

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 15: personnel training, cleansing, and garbing. International Journal of Pharmaceutical Compounding 11(5): 420-426, 2009

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 7: microbial contamination risk levels, 12-hour use, and immediate use. International Journal of Pharmaceutical Compounding 12(3): 252-257, 2008

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 20: patient or caregiver training, patient monitoring and adverse events reporting, and quality-assurance program. International Journal of Pharmaceutical Compounding 14(4): 328-331, 2010

Basics of compounding: implementing United States pharmacopeia chapter <795> pharmaceutical compounding--nonsterile preparations, part 4. International Journal of Pharmaceutical Compounding 16(1): 64-68, 2012

Considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 9: immediate use compounded sterile preparations. International Journal of Pharmaceutical Compounding 12(5): 440-443, 2008

Considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 5: verification of accuracy, sterility, and sterilization of compounded preparations. International Journal of Pharmaceutical Compounding 12(1): 54-60, 2008